Scilex Holding Company Temporary Equity, Other Changes
Scilex Holding Company (SCLX) reported Temporary Equity, Other Changes of -$41.82 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityOtherChanges · last filed 2022-11-04
- Scilex Holding Company temporary equity, other changes for the quarter ending 2022-09-30 was $0.00.
| Period end | Temporary Equity, Other Changes 3 month | Temporary Equity, Other Changes 6 month | Temporary Equity, Other Changes 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$41.82M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | -$41.82M 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |